Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | |
|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||
| Cash from operating activities | -59.61%109.2M | 29.81%270.37M | 90.61%208.29M | 109.28M |
| Net profit before non-cash adjustment | -67.08%75.96M | 36.02%230.73M | 232.14%169.63M | --51.07M |
| Total adjustment of non-cash items | 417.77%100.94M | 327.43%19.5M | 23.94%4.56M | --3.68M |
| -Depreciation and amortization | 278.03%48.92M | 56.20%12.94M | 191.32%8.29M | --2.84M |
| -Disposal profit | 16,293.11%50M | --305K | --0 | ---- |
| -Net exchange gains and losses | --0 | 200.00%4.5M | ---4.5M | ---- |
| -Other non-cash items | 15.70%2.02M | 123.72%1.75M | -6.70%780K | --836K |
| Changes in working capital | -436.13%-67.7M | -40.94%20.14M | -37.45%34.1M | --54.52M |
| -Change in receivables | -301.88%-24.07M | -25.47%11.92M | -65.15%16M | --45.91M |
| -Change in inventory | 515.79%316K | ---76K | --0 | ---- |
| -Change in payables | -712.20%-25.69M | -79.34%4.2M | 128.18%20.31M | --8.9M |
| -Change in accrued expense | -124.60%-3.22M | 784.94%13.1M | -269.65%-1.91M | --1.13M |
| -Provision for loans, leases and other losses | 247.07%2.21M | ---1.5M | --0 | ---- |
| -Changes in other current assets | -136.65%-19.86M | ---8.39M | --0 | ---1.41M |
| -Changes in other current liabilities | 193.40%2.62M | 403.05%894K | ---295K | ---- |
| Dividends paid (cash flow from operating activities) | ||||
| Dividends received (cash flow from operating activities) | ||||
| Interest paid (cash flow from operating activities) | -88.08%-3.3M | -118.85%-1.75M | 5.99%-801K | -852K |
| Interest received (cash flow from operating activities) | 15,875.00%1.28M | -61.90%8K | 31.25%21K | 16K |
| Tax refund paid | -14.23%-114.09M | -308.42%-99.87M | 138.42%47.92M | -124.72M |
| Other operating cash inflow (outflow) | 300.00%2K | -1K | 0 | 1K |
| Operating cash flow | -104.09%-6.91M | -33.93%168.75M | 1,669.26%255.43M | ---16.28M |
| Investing cash flow | ||||
| Net PPE purchase and sale | 81.15%-8.02M | -849.98%-42.54M | -17.50%-4.48M | ---3.81M |
| Net intangibles purchase and sale | 12.66%-10.35M | ---11.85M | --0 | ---- |
| Net business purchase and sale | ---198.77M | --0 | --7.31M | ---- |
| Net investment product transactions | ---1M | --0 | ---- | ---50M |
| Net changes in other investments | 113.85%2.76M | -4,088.20%-19.94M | --500K | ---- |
| Investing cash flow | -189.75%-215.38M | -2,331.49%-74.33M | 106.19%3.33M | ---53.81M |
| Financing cash flow | ||||
| Net issuance payments of debt | 43.16%-10.01M | 35.73%-17.61M | -2.75%-27.4M | ---26.66M |
| Net common stock issuance | -106.21%-42.01M | --676.2M | --0 | ---- |
| Cash dividends paid | ---30.63M | ---- | ---- | ---- |
| Net other fund-raising expenses | ---1K | ---- | ---- | ---- |
| Financing cash flow | -112.55%-82.64M | 2,503.97%658.59M | -2.75%-27.4M | ---26.66M |
| Net cash flow | ||||
| Beginning cash position | 102.16%1.49B | 45.75%737.06M | -16.06%505.69M | --602.45M |
| Current changes in cash | -140.49%-304.93M | 225.47%753.01M | 339.13%231.36M | ---96.75M |
| Cash adjustments other than cash changes | ---1K | ---- | 200.00%1K | ---1K |
| End cash Position | -20.46%1.19B | 102.16%1.49B | 45.75%737.06M | --505.69M |
| Free cash flow | -122.10%-25.28M | -54.43%114.36M | 1,349.26%250.95M | ---20.09M |
| Currency Unit | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |